15 Result(s)
within
Jocelyn Gal
Oncology
-
Article
Added value of [18F]FDOPA PET to the management of high-grade glioma patients after their initial treatment: a prospective multicentre study
Diagnostic value of 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine ([18F]FDOPA) PET in patients with suspected recurrent gliomas is recognised. We conducted a multicentre prospective study to assess its added value ...
-
Article
Open AccessPrognostic value of immunotherapy-induced organ inflammation assessed on 18FDG PET in patients with metastatic non-small cell lung cancer
We evaluated the prognostic value of immunotherapy-induced organ inflammation observed on 18FDG PET in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs).
-
Article
Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Background The phosphatidylinositol-3 kinase pathway is often altered in head and neck squamous cell carcinoma (HNSCC), and is involved in the resistance to EGFR inhibitors. Objective We investigated the dose-lim...
-
Article
Correction to: Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors
Corrections are needed to the original version of this article.
-
Article
Open AccessComment on: “Exploring the best treatment options for BRAF-mutant metastatic colon cancer”
-
Article
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors
Background Checkpoint inhibitors bring marked benefits but only in a minority of patients and may also be associated with severe adverse events. Treatment outcome still cannot be faithfully predicted. The followi...
-
Article
Open AccessFive-year oncological outcome after a single fraction of accelerated partial breast irradiation in the elderly
To update the clinical outcome of an elderly women cohort with early breast cancer who underwent accelerated partial breast irradiation (APBI) based on a post-operative single fraction of multicatheter interst...
-
Article
Correction to: 18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
Jérôme Barriere was inadvertently missing in the original version of this article. He has participated to the study design, protocol writing and inclusion of a significant number of patients.
-
Article
GEC-ESTRO APBI classification as a decision-making tool for the management of 2nd ipsilateral breast tumor event
Second ipsilateral breast tumor event (2ndIBTE) occurring after primary radio-surgical treatment can be treated by either salvage mastectomy or 2nd conservative treatment (2ndCT) including an accelerated parti...
-
Article
Open AccessLong term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer
In stage III non-small cell lung cancer (NSCLC) treated with concomitant chemoradiotherapy, there is a high rate of relapse. Some of these relapses are only local and can be treated by stereotactic ablative ra...
-
Article
18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions
This study aimed to assess the therapeutic impact and diagnostic accuracy of 18F-DOPA PET/CT in patients with glioblastoma or brain metastases.
-
Article
Open AccessSingle fraction of accelerated partial breast irradiation in the elderly: early clinical outcome
To analyze the clinical outcome of elderly women with early breast cancer who underwent accelerated partial breast irradiation (APBI) based on a post-operative single fraction of multicatheter interstitial hig...
-
Article
Open AccessCXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas
Sunitinib is one of the first-line standard treatments for metastatic clear cell renal cell carcinoma (ccRCC) with a median time to progression shorter than 1 year. The objective is to discover predictive mark...
-
Article
Open AccessHigh-dose rate brachytherapy in localized penile cancer: short-term clinical outcome analysis
To assess clinical outcomes of high-dose rate interstitial brachytherapy (HIB) in localized penile carcinoma.
-
Article
Open AccessAccelerated partial breast irradiation in the elderly: 5-year results of high-dose rate multi-catheter brachytherapy
To evaluate clinical outcome after accelerated partial breast irradiation (APBI) in the elderly after high-dose-rate interstitial multi-catheter brachytherapy (HIBT).
